RENTON HOLLINGS — SEC insider filings
SEC reporting owner CIK 1187333. 19 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2021-02-12 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 7 filings — 61,121 shares, $1,617,130 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: sale of 13,675 shares @ $23.82 ($325,782) in ANAPTYSBIO, INC, filed 2025-07-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANAPTYSBIO, INC (ANAB) | Director | 16 | — | 10 legs · 61,121 sh · $1,617,130 | 46 |
| Zymeworks Inc. (ZYME) | Director | 2 | — | — | 2 |
| Zymeworks Inc. (ZYME) | Director | 1 | — | — | 1 |
Insider filings — RENTON HOLLINGS
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,000 @ $18.03 · Sale (S): 5,000 @ $49.87 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | ANAPTYSBIO, INC (ANAB) | Disposition to issuer (D): 15,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · +14 more | EDGAR |
| 2026-01-08 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,231 @ $6.93 · Sale (S): 3,110 @ $19.44 · Sale (S): 7,121 @ $19.70 · Option exercise (M): 10,231 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 20,925 @ $6.93 · Sale (S): 7,250 @ $23.09 · Sale (S): 13,675 @ $23.82 · Option exercise (M): 20,925 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | ANAPTYSBIO, INC (ANAB) | Sale (S): 3,015 @ $23.97 | EDGAR |
| 2025-06-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,000 @ $6.93 · Sale (S): 10,000 @ $25 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,000 @ $6.93 · Sale (S): 7,103 @ $30.50 · Sale (S): 2,897 @ $30.98 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 3,900 @ $0 · Sale (S): 1,950 @ $23.16 · Option exercise (M): 3,900 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0 | EDGAR |
| 2023-12-08 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2023-01-10 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 10,600 (derivative) @ $0 · Grant/award (A): 3,900 (derivative) @ $0 | EDGAR |
| 2022-12-23 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-02-14 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 9,200 (derivative) @ $0 | EDGAR |
| 2021-05-07 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2021-02-12 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-12 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1187333 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs